{"id":"https://openalex.org/W4411074804","doi":"https://doi.org/10.7759/cureus.85377","title":"A Systematic Review of the Efficacy and Safety of Anti-amyloid Monoclonal Antibodies in Alzheimer's Disease","display_name":"A Systematic Review of the Efficacy and Safety of Anti-amyloid Monoclonal Antibodies in Alzheimer's Disease","publication_year":2025,"publication_date":"2025-06-04","ids":{"openalex":"https://openalex.org/W4411074804","doi":"https://doi.org/10.7759/cureus.85377","pmid":"https://pubmed.ncbi.nlm.nih.gov/40621323","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12227895"},"language":"en","primary_location":{"id":"doi:10.7759/cureus.85377","doi":"https://doi.org/10.7759/cureus.85377","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.85377","pdf_url":"https://www.cureus.com/articles/368193-a-systematic-review-of-the-efficacy-and-safety-of-anti-amyloid-monoclonal-antibodies-in-alzheimers-disease.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.cureus.com/articles/368193-a-systematic-review-of-the-efficacy-and-safety-of-anti-amyloid-monoclonal-antibodies-in-alzheimers-disease.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5115737776","display_name":"Umesh Chandra Chundu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I179150554","display_name":"Guntur Medical College","ror":"https://ror.org/02evmt624","country_code":"IN","type":"education","lineage":["https://openalex.org/I179150554"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Umesh C Chundu","raw_affiliation_strings":["Neurology, Guntur Medical College, Guntur, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology, Guntur Medical College, Guntur, IND","institution_ids":["https://openalex.org/I179150554"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115737775","display_name":"Sreeram Thiriveedhi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Sree Ram Thiriveedhi","raw_affiliation_strings":["Community Medicine, Katuri Medical College and Hospital, Guntur, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Community Medicine, Katuri Medical College and Hospital, Guntur, IND","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117847889","display_name":"Chetanya Bhatti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chetanya Bhatti","raw_affiliation_strings":["Family Medicine, Navjeevan Hospital Hisar, New Delhi, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Family Medicine, Navjeevan Hospital Hisar, New Delhi, IND","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5119257970","display_name":"Jaya Sai Mupparaju","orcid":"https://orcid.org/0009-0000-1368-8455","observed_orcids":["https://orcid.org/0009-0000-1368-8455"]},"institutions":[{"id":"https://openalex.org/I4403928330","display_name":"NRI Medical College","ror":"https://ror.org/00j1zdb24","country_code":"IN","type":"education","lineage":["https://openalex.org/I4403928330"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Jaya Sai Mupparaju","raw_affiliation_strings":["Internal Medicine, NRI Medical College, Vijayawada, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, NRI Medical College, Vijayawada, IND","institution_ids":["https://openalex.org/I4403928330"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093891731","display_name":"Nina Otinashvili","orcid":"https://orcid.org/0009-0004-2646-5882","observed_orcids":["https://orcid.org/0009-0004-2646-5882"]},"institutions":[{"id":"https://openalex.org/I7848551","display_name":"Tbilisi State Medical University","ror":"https://ror.org/020jbrt22","country_code":"GE","type":"education","lineage":["https://openalex.org/I7848551"]}],"countries":["GE"],"is_corresponding":false,"raw_author_name":"Nina Otinashvili","raw_affiliation_strings":["Medicine, Tbilisi State Medical University, Tbilisi, GEO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine, Tbilisi State Medical University, Tbilisi, GEO","institution_ids":["https://openalex.org/I7848551"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5117847892","display_name":"Elene Gelishvili","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I7848551","display_name":"Tbilisi State Medical University","ror":"https://ror.org/020jbrt22","country_code":"GE","type":"education","lineage":["https://openalex.org/I7848551"]}],"countries":["GE"],"is_corresponding":false,"raw_author_name":"Elene Gelishvili","raw_affiliation_strings":["Medicine, Tbilisi State Medical University, Tbilisi, GEO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine, Tbilisi State Medical University, Tbilisi, GEO","institution_ids":["https://openalex.org/I7848551"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5115737775"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.6028,"has_fulltext":true,"cited_by_count":18,"citation_normalized_percentile":{"value":0.82727273,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"17","issue":"6","first_page":"e85377","last_page":"e85377"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.007499999832361937,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-amyloid-monoclonal-antibodies","display_name":"anti-amyloid monoclonal antibodies","score":0.9399999976158142},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9940000176429749},{"id":"https://openalex.org/keywords/amyloid-plaques","display_name":"amyloid plaques","score":0.9359999895095825},{"id":"https://openalex.org/keywords/lecanemab","display_name":"lecanemab","score":0.9049999713897705},{"id":"https://openalex.org/keywords/donanemab","display_name":"donanemab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/aducanumab","display_name":"aducanumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/amyloid-related-imaging-abnormalities","display_name":"amyloid-related imaging abnormalities","score":0.9049999713897705},{"id":"https://openalex.org/keywords/cognitive-decline","display_name":"cognitive decline","score":0.7540000081062317},{"id":"https://openalex.org/keywords/amyloid-pet","display_name":"amyloid PET","score":0.6970000267028809},{"id":"https://openalex.org/keywords/cerebrospinal-fluid-biomarkers","display_name":"cerebrospinal fluid biomarkers","score":0.8960000276565552},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.9279999732971191},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.5479999780654907},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8880000114440918}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9542121887207031},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.647932231426239},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.6185383200645447},{"id":"https://openalex.org/C2777633098","wikidata":"https://www.wikidata.org/wiki/Q2736051","display_name":"Amyloid (mycology)","level":2,"score":0.5140568017959595},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4749878942966461},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.31964629888534546},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.21696126461029053}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.7759/cureus.85377","doi":"https://doi.org/10.7759/cureus.85377","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.85377","pdf_url":"https://www.cureus.com/articles/368193-a-systematic-review-of-the-efficacy-and-safety-of-anti-amyloid-monoclonal-antibodies-in-alzheimers-disease.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12227895","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12227895","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Text"},{"id":"pmid:40621323","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40621323","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.7759/cureus.85377","doi":"https://doi.org/10.7759/cureus.85377","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.85377","pdf_url":"https://www.cureus.com/articles/368193-a-systematic-review-of-the-efficacy-and-safety-of-anti-amyloid-monoclonal-antibodies-in-alzheimers-disease.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4411074804.pdf","grobid_xml":"https://content.openalex.org/works/W4411074804.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W2015484447","https://openalex.org/W2027009370","https://openalex.org/W2050386617","https://openalex.org/W2385703614","https://openalex.org/W2423611370","https://openalex.org/W2508694778","https://openalex.org/W2593927122","https://openalex.org/W2787612390","https://openalex.org/W2808506917","https://openalex.org/W2907547898","https://openalex.org/W3137826907","https://openalex.org/W3152692563","https://openalex.org/W3217122335","https://openalex.org/W4220959955","https://openalex.org/W4225741213","https://openalex.org/W4282547758","https://openalex.org/W4296286739","https://openalex.org/W4310461604","https://openalex.org/W4312128797","https://openalex.org/W4321334557","https://openalex.org/W4384522480","https://openalex.org/W4388688059","https://openalex.org/W4392083521"],"related_works":["https://openalex.org/W6939549807","https://openalex.org/W7167581374","https://openalex.org/W4394601505","https://openalex.org/W4415045389","https://openalex.org/W7117319447","https://openalex.org/W7165664571","https://openalex.org/W4388014093","https://openalex.org/W7214826548","https://openalex.org/W7128161137","https://openalex.org/W4414169209"],"abstract_inverted_index":{"Monoclonal":[0],"antibody":[1],"(mAb)":[2],"therapies":[3,80],"targeting":[4],"amyloid-beta":[5],"(A\u03b2)":[6],"plaques":[7],"have":[8,40],"gained":[9,81],"prominence":[10],"over":[11],"the":[12,32,45,54,70,76,91,125,180,207,213],"past":[13,71],"decade":[14,72],"as":[15,124],"potential":[16],"disease-modifying":[17,79],"treatments":[18],"for":[19,48,233,280],"Alzheimer's":[20,132],"disease":[21,281],"(AD),":[22],"leading":[23],"to":[24,94,167,223,238],"major":[25],"regulatory":[26],"approvals":[27],"and":[28,56,64,90,98,108,138,150,198,247,270,290,297,303],"global":[29],"debate.":[30],"Nonetheless,":[31],"central":[33],"question":[34],"persists:":[35],"does":[36],"this":[37],"emerging":[38],"therapy":[39],"a":[41,172,200,248],"justified":[42],"role":[43],"in":[44,69,169,203,235,251,254,283,294],"treatment":[46],"protocol":[47],"AD?":[49],"This":[50],"systematic":[51,84],"review":[52],"evaluates":[53],"efficacy":[55],"safety":[57,298],"of":[58,129,189],"these":[59],"agents":[60],"across":[61,88],"phase":[62,96],"II":[63,97],"III":[65,99],"clinical":[66],"trials":[67,102,144,276],"conducted":[68,104],"(2014-2024),":[73],"aligning":[74],"with":[75,187,288],"timeline":[77],"when":[78],"momentum.":[82],"A":[83],"search":[85],"was":[86,175],"performed":[87],"PubMed":[89],"Cochrane":[92],"Library":[93],"identify":[95],"randomized":[100],"controlled":[101],"(RCTs)":[103],"between":[105],"January":[106],"2014":[107],"December":[109],"2024.":[110],"The":[111],"inclusion":[112,181],"criteria":[113],"focused":[114],"on":[115,206,262],"studies":[116],"that":[117],"evaluated":[118],"cognitive":[119,204,252,268,295],"outcomes":[120,269,296],"using":[121],"scales":[122],"such":[123],"Clinical":[126],"Dementia":[127],"Rating-Sum":[128],"Boxes":[130],"(CDR-SB),":[131],"Disease":[133,217],"Assessment":[134],"Scale-Cognitive":[135],"Subscale":[136],"(ADAS-Cog),":[137],"Mini-Mental":[139],"State":[140],"Examination":[141],"(MMSE).":[142],"Additionally,":[143],"assessing":[145],"biomarkers,":[146],"including":[147],"CSF":[148],"measures":[149],"PET":[151,193],"imaging,":[152],"were":[153,162],"included.":[154],"Safety":[155],"outcomes,":[156],"particularly":[157,287],"amyloid-related":[158],"imaging":[159],"abnormalities":[160],"(ARIA),":[161],"also":[163],"systematically":[164],"analyzed.":[165],"Due":[166],"heterogeneity":[168],"outcome":[170],"measures,":[171],"narrative":[173],"synthesis":[174],"conducted.":[176],"Sixteen":[177],"RCTs":[178],"met":[179],"criteria.":[182],"Lecanemab":[183],"reduced":[184],"amyloid":[185],"burden":[186],"81%":[188],"patients":[190],"achieving":[191],"amyloid-negative":[192],"scans":[194],"(Clarity":[195],"AD":[196,256,285],"trial)":[197],"showed":[199,259],"27%":[201,214],"reduction":[202,220],"decline":[205,253],"ADCOMS":[208,215],"scale.":[209],"While":[210],"statistically":[211],"significant,":[212],"(Alzheimer's":[216],"Composite":[218],"Score)":[219],"warrants":[221],"comparison":[222],"MCID":[224],"(minimal":[225],"clinically":[226],"important":[227],"difference)":[228],"thresholds":[229],"(e.g.,":[230],"~0.5-1.0":[231],"points":[232],"CDR-SB":[234],"early":[236,255,284],"AD)":[237],"assess":[239],"real-world":[240],"impact.":[241],"Donanemab":[242],"demonstrated":[243],"76%":[244],"plaque":[245,263],"clearance":[246,264],"35%":[249],"slowing":[250],"patients.":[257],"Aducanumab":[258],"dose-dependent":[260],"effects":[261],"but":[265],"had":[266],"inconsistent":[267],"higher":[271],"ARIA":[272],"rates.":[273],"Recent":[274],"mAb":[275],"provide":[277],"promising":[278],"evidence":[279],"modification":[282],"stages,":[286],"lecanemab":[289],"donanemab.":[291],"However,":[292],"variability":[293],"concerns":[299],"warrant":[300],"cautious":[301],"interpretation":[302],"long-term":[304],"validation.":[305]},"counts_by_year":[{"year":2026,"cited_by_count":14},{"year":2025,"cited_by_count":4}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2025-10-10T00:00:00"}